Chieh-Hung Wu

454 total citations
12 papers, 359 citations indexed

About

Chieh-Hung Wu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Chieh-Hung Wu has authored 12 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Chieh-Hung Wu's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Research Studies (4 papers). Chieh-Hung Wu is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Research Studies (4 papers). Chieh-Hung Wu collaborates with scholars based in Taiwan and United States. Chieh-Hung Wu's co-authors include Yuh-Min Chen, Yu-Chin Lee, CHING‐TAI TAI, Ming-Hsiung Hsieh, Chun-Ming Tsai, Chin-Feng Tsai, Chuen‐Wang Chiou, Shih‐Ann Chen, Reury-Perng Perng and Mau-Song Chang and has published in prestigious journals such as Circulation, PLoS ONE and Journal of Thoracic Oncology.

In The Last Decade

Chieh-Hung Wu

12 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chieh-Hung Wu Taiwan 11 159 137 136 42 34 12 359
Shih‐Hong Li Taiwan 9 239 1.5× 17 0.1× 128 0.9× 27 0.6× 39 1.1× 22 314
E Viel Italy 11 52 0.3× 187 1.4× 150 1.1× 38 0.9× 21 0.6× 20 310
Cinzia Nobili Italy 10 102 0.6× 33 0.2× 165 1.2× 192 4.6× 14 0.4× 18 333
Franco Ragni Italy 7 49 0.3× 40 0.3× 61 0.4× 44 1.0× 19 0.6× 29 169
R. V. Iaffaioli Italy 8 43 0.3× 35 0.3× 141 1.0× 40 1.0× 41 1.2× 20 226
Christina Villard Sweden 11 211 1.3× 94 0.7× 36 0.3× 120 2.9× 15 0.4× 28 305
Shobhit Baijal United Kingdom 6 51 0.3× 41 0.3× 91 0.7× 39 0.9× 18 0.5× 27 155
Makoto Yano Japan 7 98 0.6× 45 0.3× 64 0.5× 64 1.5× 8 0.2× 22 224
Anna Morelli Italy 7 61 0.4× 28 0.2× 56 0.4× 13 0.3× 31 0.9× 19 153
José Manuel López Vega Spain 6 41 0.3× 25 0.2× 93 0.7× 18 0.4× 15 0.4× 9 173

Countries citing papers authored by Chieh-Hung Wu

Since Specialization
Citations

This map shows the geographic impact of Chieh-Hung Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chieh-Hung Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chieh-Hung Wu more than expected).

Fields of papers citing papers by Chieh-Hung Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chieh-Hung Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chieh-Hung Wu. The network helps show where Chieh-Hung Wu may publish in the future.

Co-authorship network of co-authors of Chieh-Hung Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chieh-Hung Wu. A scholar is included among the top collaborators of Chieh-Hung Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chieh-Hung Wu. Chieh-Hung Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Chiang, Chi‐Lu, Yu‐Wen Hu, Chieh-Hung Wu, et al.. (2016). Spectrum of cancer risk among Taiwanese with chronic obstructive pulmonary disease. International Journal of Clinical Oncology. 21(5). 1014–1020. 16 indexed citations
3.
Luo, Yung‐Hung, Chian‐Shiu Chien, Chieh-Hung Wu, et al.. (2016). Induced Pluripotent Stem Cell–conditioned Medium Suppressed Melanoma Tumorigenicity Through the Enhancement of Natural-Killer Cellular Immunity. Journal of Immunotherapy. 39(4). 153–159. 4 indexed citations
4.
Chen, Yuh-Min, Chieh-Hung Wu, Chun-Ming Tsai, et al.. (2014). Circulating free mitochondrial DNA concentration and its association with erlotinib treatment in patients with adenocarcinoma of the lung. Oncology Letters. 7(6). 2180–2184. 10 indexed citations
5.
Lee, Ming‐Che, Shiang‐Fen Huang, Chao‐Hua Chiu, et al.. (2014). Latent TB infection in newly diagnosed lung cancer patients – A multicenter prospective observational study. Lung Cancer. 85(3). 472–478. 24 indexed citations
6.
Chen, Yuh-Min, Chun-Ming Tsai, Shih-Hao Liu, et al.. (2011). A Phase II Randomized Trial of Gefitinib Alone or with Tegafur/Uracil Treatment in Patients with Pulmonary Adenocarcinoma Who had Failed Previous Chemotherapy. Journal of Thoracic Oncology. 6(6). 1110–1116. 23 indexed citations
7.
Chen, Yuh-Min, Chun-Ming Tsai, Jen-Fu Shih, et al.. (2011). Phase II Randomized Trial of Erlotinib or Vinorelbine in Chemonaive, Advanced, Non-small Cell Lung Cancer Patients Aged 70 Years or Older. Journal of Thoracic Oncology. 7(2). 412–418. 51 indexed citations
8.
Chen, Yuh-Min, Jen-Fu Shih, Chieh-Hung Wu, et al.. (2011). Third-line or fourth-line chemotherapy in non-small-cell lung cancer patients with relatively good performance status. Journal of the Chinese Medical Association. 74(5). 209–214. 16 indexed citations
9.
Chen, Yuh-Min, Chun-Ming Tsai, Teh‐Ying Chou, et al.. (2011). Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinib. Oncology Letters. 3(3). 713–717. 12 indexed citations
10.
Wu, Wen‐Shuo, Yuh-Min Chen, Chun-Ming Tsai, et al.. (2011). Erlotinib has better efficacy than gefitinib in adenocarcinoma patients without EGFR-activating mutations, but similar efficacy in patients with EGFR-activating mutations. Experimental and Therapeutic Medicine. 3(2). 207–213. 17 indexed citations
11.
Yu, Chong‐Jen, Chun-Ming Tsai, Ming-Shyan Huang, et al.. (2010). Different Efficacies of Erlotinib and Gefitinib in Taiwanese Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Multicenter Study. Journal of Thoracic Oncology. 6(1). 148–155. 26 indexed citations
12.
Hsieh, Ming-Hsiung, Chuen‐Wang Chiou, Zu‐Chi Wen, et al.. (1999). Alterations of Heart Rate Variability After Radiofrequency Catheter Ablation of Focal Atrial Fibrillation Originating From Pulmonary Veins. Circulation. 100(22). 2237–2243. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shih‐Hong Li Breakdown of academic impact, for papers by E Viel Breakdown of academic impact, for papers by Cinzia Nobili Breakdown of academic impact, for papers by Franco Ragni Breakdown of academic impact, for papers by R. V. Iaffaioli Breakdown of academic impact, for papers by Christina Villard Breakdown of academic impact, for papers by Shobhit Baijal Breakdown of academic impact, for papers by Makoto Yano Breakdown of academic impact, for papers by Anna Morelli Breakdown of academic impact, for papers by José Manuel López Vega
Rankless by CCL
2026